Status:
COMPLETED
Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury
Lead Sponsor:
University of North Carolina, Chapel Hill
Conditions:
Drug Induced Liver Injury
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver.
Detailed Description
Our hypothesis is that there are liver-specific particles, called mRNA, that are identifiable in a person's blood sample during liver injury caused by some drugs. The purpose of this study is to try t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- ALT \> 200 IU/L at presentation to UNC Hospitals
- Drug induced liver injury considered likely by admitting medical staff
Exclusion
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01000766
Start Date
September 1 2009
End Date
December 1 2013
Last Update
April 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599